About Non-Invasive Prenatal Testing (NIPT)
As the baby grows in the mother’s womb, a small amount of the baby’s DNA will enter the mother’s bloodstream. NIPT is a non-invasive blood test that able to screen the baby’s DNA for certain abnormalities caused by extra or missing chromosome material.
A Non-invasive Blood Test That Screens For Common Chromosomal Abnormalities As Early As 10th Week Of Gestation.
![](https://biotech.stemlife.com/wp-content/uploads/2020/07/Icon_Web-01-400x400.png)
Up to 142 conditions including trisomies, sex chromosomes and microdeletions.
![](https://biotech.stemlife.com/wp-content/uploads/2020/07/Icon_Web-02-400x400.png)
Can be performed as early as on the 10th week of pregnancy.
![](https://biotech.stemlife.com/wp-content/uploads/2020/07/Icon_Web-05-400x400.png)
More than 99% accurate.
![](https://biotech.stemlife.com/wp-content/uploads/2020/07/Icon_Web-03-400x400.png)
Option to know your baby’s
gender.
![](https://biotech.stemlife.com/wp-content/uploads/2020/07/Icon_Web-04-400x400.png)
Whole Genome Sequencing (WGS)
method is employed for
comprehensive coverage of all
chromosomes.
![](https://biotech.stemlife.com/wp-content/uploads/2020/07/Icon_Web-06-400x400.png)
Tested by internationally-certified laboratory
in South Korea.
![](https://biotech.stemlife.com/wp-content/uploads/2020/07/Icon_Web-08-400x400.png)
Up to US$300^ confirmatory testing subsidy
for patients with reported
high-risk chromosomal abnormalities.